NeoGenomics, Inc. (NEO)
NASDAQ: NEO · Real-Time Price · USD
13.94
-0.20 (-1.42%)
Nov 5, 2024, 11:14 AM EST - Market open
NeoGenomics Employees
NeoGenomics had 2,100 employees as of December 31, 2023. The number of employees did not change compared to the previous year.
Employees
2,100
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$306,723
Profits / Employee
-$37,013
Market Cap
1.79B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
National HealthCare | 13,123 |
Patterson Companies | 7,600 |
NovoCure | 1,453 |
Galapagos NV | 1,123 |
BioCryst Pharmaceuticals | 536 |
Recursion Pharmaceuticals | 500 |
Beam Therapeutics | 436 |
Nurix Therapeutics | 284 |
NEO News
- 4 hours ago - NeoGenomics Reports Third Quarter 2024 Results - Business Wire
- 14 days ago - NeoGenomics Receives New York State Approval for Neo Comprehensive™ Solid Tumor Test - Business Wire
- 21 days ago - NeoGenomics to Report Third Quarter 2024 Financial Results on Nov. 5, 2024 - Business Wire
- 4 weeks ago - NeoGenomics Launches AML Express for Rapid Genetic Profiling of Acute Myeloid Leukemia - Business Wire
- 4 weeks ago - NeoGenomics Inc (NEO) Shares Up 3.95% on Oct 2 - GuruFocus
- 6 weeks ago - NeoGenomics Announces New RaDaR Technology and Resolution of RaDaR 1.0 Litigation - Business Wire
- 7 weeks ago - NeoGenomics to Present New Data at ESMO 2024, Highlighting the Value of ctDNA and NGS for Advancing Cancer Diagnostics and Personalized Treatment - Business Wire
- 2 months ago - NeoGenomics to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference - Business Wire